223 related articles for article (PubMed ID: 38277554)
1. Research progress and perspectives of noncoding RNAs in adrenocortical carcinoma: A review.
Xu C; Xu P; Zhang J; He S; Hua T; Huang A
Medicine (Baltimore); 2024 Jan; 103(4):e36908. PubMed ID: 38277554
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma.
Detomas M; Pivonello C; Pellegrini B; Landwehr LS; Sbiera S; Pivonello R; Ronchi CL; Colao A; Altieri B; De Martino MC
Cells; 2022 Jul; 11(14):. PubMed ID: 35883677
[TBL] [Abstract][Full Text] [Related]
3. Pathological stage-associated non-coding RNA long intergenic non-protein coding RNA 1234 (LINC01234) participation in cell cycle regulation in adrenocortical carcinoma through bromodomain-containing protein 4 (BRD4) expression mediation via sponging microRNA (miR)-140-3p.
Zhu DD; Yu XB; Jiang W; Zhu Y
Bioengineered; 2022 May; 13(5):13607-13621. PubMed ID: 35765893
[TBL] [Abstract][Full Text] [Related]
4. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence.
Glover AR; Zhao JT; Ip JC; Lee JC; Robinson BG; Gill AJ; Soon PS; Sidhu SB
Endocr Relat Cancer; 2015 Feb; 22(1):99-109. PubMed ID: 25595289
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA circ-CCAC1 Facilitates Adrenocortical Carcinoma Cell Proliferation, Migration, and Invasion through Regulating the miR-514a-5p/C22orf46 Axis.
Li W; Liu R; Wei D; Zhang W; Zhang H; Huang W; Hao L
Biomed Res Int; 2020; 2020():3501451. PubMed ID: 33195693
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Buishand FO; Liu-Chittenden Y; Fan Y; Tirosh A; Gara SK; Patel D; Meerzaman D; Kebebew E
Surgery; 2020 Jan; 167(1):224-232. PubMed ID: 31522749
[TBL] [Abstract][Full Text] [Related]
8. miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance.
El-Dakroury WA; Midan HM; Abulsoud AI; Elshaer SS; El-Husseiny AA; Fathi D; Abdelmaksoud NM; Abdel Mageed SS; Elballal MS; Zaki MB; Abd-Elmawla MA; Al-Noshokaty TM; Rizk NI; Elrebehy MA; Hashem AH; Moustafa YM; Doghish AS
Pathol Res Pract; 2023 Aug; 248():154665. PubMed ID: 37418996
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma.
Glover AR; Zhao JT; Gill AJ; Weiss J; Mugridge N; Kim E; Feeney AL; Ip JC; Reid G; Clarke S; Soon PS; Robinson BG; Brahmbhatt H; MacDiarmid JA; Sidhu SB
Oncotarget; 2015 Nov; 6(34):36675-88. PubMed ID: 26452132
[TBL] [Abstract][Full Text] [Related]
10. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
Özata DM; Caramuta S; Velázquez-Fernández D; Akçakaya P; Xie H; Höög A; Zedenius J; Bäckdahl M; Larsson C; Lui WO
Endocr Relat Cancer; 2011 Oct; 18(6):643-55. PubMed ID: 21859927
[TBL] [Abstract][Full Text] [Related]
11. Roles of noncoding RNAs in septic acute kidney injury.
Yue L; Gu Y; Xu J; Liu T
Biomed Pharmacother; 2023 Sep; 165():115269. PubMed ID: 37541179
[TBL] [Abstract][Full Text] [Related]
12. The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma - A focus on signaling pathways interplay.
Midan HM; Helal GK; Abulsoud AI; Elshaer SS; El-Husseiny AA; Fathi D; Abdelmaksoud NM; Abdel Mageed SS; Elballal MS; Zaki MB; Abd-Elmawla MA; Al-Noshokaty TM; Rizk NI; Elrebehy MA; El-Dakroury WA; Hashem AH; Doghish AS
Pathol Res Pract; 2023 Aug; 248():154690. PubMed ID: 37473498
[TBL] [Abstract][Full Text] [Related]
13. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
14. Non-coding RNA dysregulation in skin cancers.
Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
[TBL] [Abstract][Full Text] [Related]
15. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.
Feng Q; Zhang H; Yao D; Chen WD; Wang YD
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905958
[TBL] [Abstract][Full Text] [Related]
16. The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling.
Gao J; Xu W; Wang J; Wang K; Li P
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287427
[TBL] [Abstract][Full Text] [Related]
17. Multi-genomic analysis of 260 adrenocortical cancer patient tumors identifies novel network BIRC5-hsa-miR-335-5p-PAX8-AS1 strongly associated with poor survival.
Subramanian C; McCallister R; Cohen MS
Surgery; 2023 Jan; 173(1):43-51. PubMed ID: 36202651
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications.
Zhang Y; Zhan L; Jiang X; Tang X
Biochem Pharmacol; 2024 Jun; 224():116218. PubMed ID: 38643906
[TBL] [Abstract][Full Text] [Related]
19. Decoding hepatocarcinogenesis from a noncoding RNAs perspective.
El-Aziz MKA; Dawoud A; Kiriacos CJ; Fahmy SA; Hamdy NM; Youness RA
J Cell Physiol; 2023 Sep; 238(9):1982-2009. PubMed ID: 37450612
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.
Chabre O; Libé R; Assie G; Barreau O; Bertherat J; Bertagna X; Feige JJ; Cherradi N
Endocr Relat Cancer; 2013 Aug; 20(4):579-94. PubMed ID: 23756429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
